Clinical Trials in South Dakota (SD) | South Dakota Clinical Drug Trials & Studies

You are viewing Clinical Trials In South Dakota

Have multiple conditions? Click here

Showing 1-100 of 302

There are 302 trials in South Dakota

Name	City	State	Zip
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder	Watertown	SD	57201
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Sioux Falls	SD	57105
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma	Sioux Falls	SD	57105
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor	Sioux Falls	SD	57105
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Sioux Falls	SD	57105
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	Sioux Falls	SD	57105
Study of Late-Occurring Complications in Childhood Cancer Survivors	Sioux Falls	SD	57105
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer	Sioux Falls	SD	57105
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Sioux Falls	SD	57105
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Sioux Falls	SD	57105
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer	Sioux Falls	SD	57105
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Sioux Falls	SD	57105
VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer	Sioux Falls	SD	57105
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	Sioux Falls	SD	57105
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Sioux Falls	SD	57105
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Sioux Falls	SD	57105
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia	Sioux Falls	SD	57105
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Sioux Falls	SD	57105
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Sioux Falls	SD	57105
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Sioux Falls	SD	57105
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Sioux Falls	SD	57105
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer	Sioux Falls	SD	57105
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Sioux Falls	SD	57105
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Sioux Falls	SD	57105
Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells	Sioux Falls	SD	57105
Collecting Tumor Samples From Patients With Gynecological Tumors	Sioux Falls	SD	57105
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	Sioux Falls	SD	57105
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Sioux Falls	SD	57105
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Sioux Falls	SD	57105
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Sioux Falls	SD	57105
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors	Sioux Falls	SD	57105
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction	Sioux Falls	SD	57105
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Sioux Falls	SD	57105
Stem Cell Related Donor Safety Study	Sioux Falls	SD	57105
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Sioux Falls	SD	57105
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer	Sioux Falls	SD	57105
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Sioux Falls	SD	57105
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery	Sioux Falls	SD	57105
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma	Sioux Falls	SD	57105
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	Sioux Falls	SD	57105
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Sioux Falls	SD	57105
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma	Sioux Falls	SD	57105
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer	Sioux Falls	SD	57105
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer	Sioux Falls	SD	57105
Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia	Sioux Falls	SD	57105
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	Sioux Falls	SD	57105
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Sioux Falls	SD	57105
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Sioux Falls	SD	57105
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia	Sioux Falls	SD	57105
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer	Sioux Falls	SD	57105
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Sioux Falls	SD	57105
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	Sioux Falls	SD	57105
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Sioux Falls	SD	57105
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Sioux Falls	SD	57105
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Sioux Falls	SD	57105
Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	Sioux Falls	SD	57105
Acute Pain Caused by Paclitaxel in Patients With Cancer	Sioux Falls	SD	57105
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Sioux Falls	SD	57105
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer	Sioux Falls	SD	57105
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Sioux Falls	SD	57105
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Sioux Falls	SD	57105
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Sioux Falls	SD	57105
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	Sioux Falls	SD	57105
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer	Sioux Falls	SD	57105
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary	Sioux Falls	SD	57105
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer	Sioux Falls	SD	57105
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Sioux Falls	SD	57105
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma	Sioux Falls	SD	57105
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Sioux Falls	SD	57105
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Sioux Falls	SD	57105
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery	Sioux Falls	SD	57105
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Sioux Falls	SD	57105
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	Sioux Falls	SD	57105
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer	Sioux Falls	SD	57105
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer	Sioux Falls	SD	57105
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer	Sioux Falls	SD	57105
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Sioux Falls	SD	57105
Carotid Stenting vs. Surgery of Severe Carotid Artery Disease and Stroke Prevention in Asymptomatic Patients (ACT I)	Sioux Falls	SD	57108
The Dual Antiplatelet Therapy Study (DAPT Study)	Sioux Falls	SD	57108
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)	Sioux Falls	SD
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products	Sioux Falls	SD
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry	Sioux Falls	SD
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC	Sioux Falls	SD
Medtronic Shock-Less Study	Sioux Falls	SD
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study	Sioux Falls	SD
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs	Sioux Falls	SD
Study of AdacelÂ® Vaccine Administered to Persons 10 Years of Age	Sioux Falls	SD
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol	Sioux Falls	SD
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study	Sioux Falls	SD
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza	Sioux Falls	SD
Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza	Sioux Falls	SD
4965 Post-approval Study	Sioux Falls	SD
4968 Post-approval Study	Sioux Falls	SD
nEw3 Post-approval Study	Sioux Falls	SD
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout	Sioux Falls	SD
A Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)	Sioux Falls	SD
Conversion to Embeda With Rescue Trial	Sioux Falls	SD
MP-376 (Aeroquinâ„¢, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis	Sioux Falls	SD
A Study of Trastuzumab-DM1 (T-DM1) Sequentially With Anthracycline-Based Chemotherapy, As Adjuvant or Neoadjuvant Therapy for Patients With Early Stage HER2-Positive Breast Cancer	Sioux Falls	SD
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Sioux Falls	SD	57104

View Clinical Trial Facilities in South Dakota

Showing 1-100 of 302